Medvi, a telehealth provider specializing in GLP-1 medications, has emerged as a significant player in the healthcare sector since its inception in September 2024. Founded by Matthew Gallagher with an initial investment of just $20,000, Medvi has leveraged artificial intelligence and strategic partnerships to achieve remarkable growth. By the end of 2025, the company reported sales of $401 million and a customer base of 250,000.
The company’s trajectory has been nothing short of extraordinary, with projections indicating that Medvi could reach $1.8 billion in sales by the end of 2026. Gallagher attributes this rapid expansion to the innovative use of AI tools, including ChatGPT, Claude, and Grok, which have enabled a lean operational model. “Growth was insane,” Gallagher remarked, reflecting on the company’s swift rise.
In February 2026, Medvi launched a dedicated men’s health line, which quickly gained traction, attracting 50,000 customers within its first month. This expansion is part of Medvi’s strategy to cater to a growing demand for specialized healthcare services. The company’s net profit margin stood at an impressive 16.2% in 2025, showcasing its financial viability.
Industry experts have noted that Medvi’s success exemplifies the potential of AI in transforming traditional business models. Jon Lensing, a prominent figure in the tech community, commented, “Matthew’s native tongue seems to be A.I.,” highlighting Gallagher’s adeptness in utilizing technology to drive business growth. Furthermore, Sam Altman, CEO of OpenAI, previously predicted that AI would enable individuals to build billion-dollar companies, a vision that Medvi appears to be realizing.
As Medvi continues to innovate and expand its offerings, observers are keenly watching how the company will navigate the competitive telehealth landscape. Fortune magazine has pointed out that Medvi serves as proof that AI is enabling ultra-lean, hyper-scalable companies, a trend that could reshape the future of healthcare.
Looking ahead, the company is expected to maintain its aggressive growth strategy, potentially introducing new services and expanding its customer base further. However, as with any rapidly growing business, challenges may arise, and details remain unconfirmed regarding how Medvi plans to sustain its momentum in the coming years.